Table I.
Drug and Dosage | Day |
---|---|
EZN-3042 (dose assigned at study entry) | −5, −2, 8, 15, 22, 29 |
Vincristine 1.5 mg/m2 IV | 1, 8, 15, 22 |
Prednisone 40 mg/m2/day PO | 1–29 |
Pegaspargase 2500 IU/m2 IV | 2, 9, 16, 23 |
Doxorubicin 60 mg/m2 IV | 1 |
Intrathecal cytarabine | 0 |
Intrathecal methotrexate | 15 and 36 (CNS negative) |
Triple intrathecal chemotherapy | 8, 15, 22, 29 (CNS positive) |